Subject Areas on Research
- RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.
- Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients.
- Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.
- Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin.